2017 hotspots review and outlook on gastric cancer surgery in China.
- Author:
Zhenggang ZHU
1
Author Information
1. Department of Surgery, Shanghai Institute of Digestive Surgery, Shanghai Key Laboratory of Gastric Neoplasm, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. zzg1954@hotmail.com.
- Publication Type:Journal Article
- From:
Chinese Journal of Gastrointestinal Surgery
2018;21(1):7-14
- CountryChina
- Language:Chinese
-
Abstract:
The 12th International Gastric Cancer Congress (12th IGCC ) was successfully held in Beijing, China on 20th-23rd April, 2017, which gave Chinese surgeons a great opportunity to share clinical progress and experience in the surgical treatment of gastric cancer with colleagues from different countries. At the end of 2017, this article hereby reviews briefly the achievements of surgical work of gastric cancer, which was done by our Chinese surgeons in this year. Some aspects will be reviewed, aiming at summarizing experience, affirming achievement, finding out the gap and promoting improvement in the future. These aspects include the conversion therapy for stageIIII( gastric cancer; the minimally invasive surgery for gastric cancer; the alimentary tract reconstruction after gastrectomy; enhanced recovery after radical gastrectomy and surgery quality control and patient's quality of life after surgery. In 2017, the gastric cancer surgery in China has made some new progress in many fields, and some achievements have reached or are close to international advanced level. However, looking ahead to the coming year and the future, there are still some important works to be done in the field of clinical surgery for gastric cancer in China, which include (1) strengthening big clinical data in gastric cancer collection and analysis platform construction for the promotion of scientific decision in therapeutic strategy; (2) further participating in international academic exchange and cooperation with taking advantages of our big number of gastric cancer cases, great amount of bio-tissue samples and big number of professional surgeons to actively join the international clinical research and expand our academic influence in the world;(3)developing more multicentre prospective randomized controlled trials in order to further improve the scientific significance in Chinese clinical guideline, norms and expert consensus in surgical treatment for gastric cancer; (4) further improving effectiveness of the multidisciplinary team (MDT) model in order to truly play the role of each subject in resolving some difficult cases; (5) in terms of surgical treatment for patients, it should be continue to keep going on minimally invasive operation, rational perioperative treatment, refinement technique, radical cure resection, and to further improve operation quality control system, aiming at realizing both goals simultaneously in prolonging survival time and improving quality of life for the patients with gastric cancer.
